BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37455402)

  • 1. Genetic mutations in smoking-associated prostate cancer.
    Elshafei A; Al-Toubat M; Feibus AH; Koul K; Jazayeri SB; Lelani N; Henry V; Balaji KC
    Prostate; 2023 Sep; 83(13):1229-1237. PubMed ID: 37455402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
    Al-Toubat M; Serrano S; Elshafei A; Koul K; Feibus AH; Balaji KC
    Urol Oncol; 2023 Nov; 41(11):455.e7-455.e15. PubMed ID: 37838503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
    Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
    Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer.
    Economides MP; Nakazawa M; Lee JW; Li X; Hollifield L; Chambers R; Sarfaty M; Goldberg JD; Antonarakis ES; Wise DR
    Clin Genitourin Cancer; 2024 Feb; 22(1):e31-e37.e1. PubMed ID: 37482523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.
    Huang CC; Cheng YW; Chen MC; Lin YS; Chou MC; Lee H
    Environ Mol Mutagen; 2006 Aug; 47(7):527-32. PubMed ID: 16721749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.
    Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B
    Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of smoking on outcome following external radiation for localized prostate cancer.
    Pickles T; Liu M; Berthelet E; Kim-Sing C; Kwan W; Tyldesley S;
    J Urol; 2004 Apr; 171(4):1543-6. PubMed ID: 15017216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.
    Choucair K; Ejdelman J; Brimo F; Aprikian A; Chevalier S; Lapointe J
    BMC Cancer; 2012 Nov; 12():543. PubMed ID: 23171135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer.
    Hashim D; Gonzalez-Feliciano AG; Ahearn TU; Pettersson A; Barber L; Pernar CH; Ebot EM; Isikbay M; Finn SP; Giovannucci EL; Lis RT; Loda M; Parmigiani G; Lotan T; Kantoff PW; Mucci LA; Graff RE
    Int J Cancer; 2020 May; 146(10):2694-2702. PubMed ID: 31318977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco smoking and somatic mutations in human bronchial epithelium.
    Yoshida K; Gowers KHC; Lee-Six H; Chandrasekharan DP; Coorens T; Maughan EF; Beal K; Menzies A; Millar FR; Anderson E; Clarke SE; Pennycuick A; Thakrar RM; Butler CR; Kakiuchi N; Hirano T; Hynds RE; Stratton MR; Martincorena I; Janes SM; Campbell PJ
    Nature; 2020 Feb; 578(7794):266-272. PubMed ID: 31996850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study.
    Martínez F; Fernández-Martos C; Quintana MJ; Castells A; Llombart A; Ińiguez F; Guillem V; Dasí F
    Clin Transl Oncol; 2011 Sep; 13(9):664-71. PubMed ID: 21865138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mutations associated with cigarette smoking in pancreatic cancer.
    Blackford A; Parmigiani G; Kensler TW; Wolfgang C; Jones S; Zhang X; Parsons DW; Lin JC; Leary RJ; Eshleman JR; Goggins M; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Klein A; Cameron JL; Olino K; Schulick R; Winter J; Vogelstein B; Velculescu VE; Kinzler KW; Hruban RH
    Cancer Res; 2009 Apr; 69(8):3681-8. PubMed ID: 19351817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
    Dong JT; Li CL; Sipe TW; Frierson HF
    Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of smoking and donor age on the spectrum of in vivo mutation at the HPRT-locus in T lymphocytes of healthy adults.
    Podlutsky A; Hou SM; Nyberg F; Pershagen G; Lambert B
    Mutat Res; 1999 Dec; 431(2):325-39. PubMed ID: 10635998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What do prostate cancer patients know about smoking? : Results of a bicentric questionnaire study (KRAUT study)].
    May M; Gilfrich C; Spachmann P; Maurer O; Dombrowski MK; Fritsche HM; Wöhr M; Brookman-May S; Karl T; Schostak M; Burger M; Lebentrau S
    Urologe A; 2016 Aug; 55(8):1078-85. PubMed ID: 27364819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
    Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
    Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.